Mouse intraductal modeling of primary ductal carcinoma in situ

Stefan J. Hutten(The Netherlands Cancer Institute), Jos Jonkers(The Netherlands Cancer Institute)

STAR Protocols

August 30, 2023

10.1016/j.xpro.2023.102526

Cited by 2

Related Papers

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

|Nature Structural & Molecular Biology|2010|1k

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

|Nature|2022|130

MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

|Nature Communications|2022|130

CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer

|Nature Communications|2023|112

Functional Categorization of <i>BRCA1</i> Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays

|Clinical Cancer Research|2020|39